Quality Management System for Life Sciences

QDMS for Pharma is developed in full compliance with GxP requirements. Alignment with EU GMP Annex 11, ISO 13485, and FDA 21 CFR Part 11 ensures that all processes remain secure, compliant, and auditable across regions. The system is delivered with a pre-executed and approved validation documentation package, enabling organizations to focus on operational adoption without building validation from scratch.

All quality documentation is managed within a centralized system with version control and role-based access. CAPA processes are directly linked to audit findings, deviations, and incident reports. Approval workflows, responsibilities, and deadlines are transparently tracked, eliminating manual errors and document fragmentation while ensuring a complete audit trail.

Internal and external audits are planned, executed, and followed up digitally end-to-end. Audit findings, nonconformities, deviations, change management, and CAPA actions are monitored within a single platform. Historical audit data supports continuous improvement and ensures audits become controlled and predictable processes.

QDMS provides a fully integrated modular structure including Document Management, CAPA, Audit Management, Customer Complaints, Change Management, Deviation Management, Incident Reporting, Training Management, Equipment Management, Supplier Evaluation, and Action Management. All modules operate cohesively to ensure end-to-end quality governance and prevent fragmented processes.

Role-based authorization ensures controlled access to critical quality data. Dashboards and reports provide visibility into performance, while risks, delays, and bottlenecks are identified proactively. Mobile access and notifications ensure quality management remains connected across sites and teams.